T1	Participants 0 82	Lack of benefit of intravenous synthetic human secretin in the treatment of autism
T2	Participants 117 250	to determine if an intravenous infusion of synthetic human secretin improves language and behavioral symptoms in children with autism
T3	Participants 252 299	Forty-two children with the diagnosis of autism
T4	Participants 475 530	an equal volume of intravenous saline placebo at week 6
T5	Participants 627 724	1, 3, 6, 9, and 12 with standardized assessments of language, behavior, and autism symptomatology
T6	Participants 934 989	study do not support secretin as a treatment for autism
